NantKwest

About:

NantKwest is a clinical-stage immunotherapy company focused on harnessing the immune system to treat disease.

Website: http://www.nantkwest.com

Twitter/X: nantkwest

Top Investors: Patrick Soon-Shiong

Description:

NantKwest is a clinical-stage immunotherapy company focused on harnessing the immune system to treat disease. It is a biotechnology company, engages in developing immunotherapeutic agents for various clinical conditions in the United States. The company’s product candidates include activated natural killer candidates for the treatment of virally-induced cancers, such as human papilloma virus-induced cervical, and head and neck cancers; ebola; and serious viral, fungal, and bacterial infections, as well as that is in Phase II clinical trials for the treatment of polyoma virus-induced merkel cell carcinoma.